Skip to search boxSkip to navigationSkip to main content

Reactive oxygen and NF-κB in VEGF-induced migration of human vascular smooth muscle cells

  • Zhongbiao Wang(corresponding author)
    ,
  • Manuel R. Castresana
    ,
  • Walter H. Newman
*Corresponding author for this work
  • Mercer University
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

Migration and proliferation of vascular smooth muscle cells (VSMC) contribute to angiogenesis and the lesions of atherosclerosis. Since, vascular endothelial growth factor (VEGF) is overexpressed by VSMC in intima of atherosclerotic human coronary arteries, we determined if VEGF could stimulate VSMC migration and the intracellular signals involved. VEGF induced VSMC migration but had no significant activity on proliferation. VEGF increased intracellular reactive oxygen species (RES), NF-κB activation and IL-6 expression. Blockade of the generation of intracellular ROS by antioxidants inhibited VEGF-induced NF-κB activation, IL-6 expression, and cell migration indicating that generation of Res was required for NF-κB activation and the chemotactic activity of VEGF. Expression of a mutated, nondegradable form of inhibitor of NF-κB (IκB-αM) suppressed VEGF-triggered activation of NF-κB and upregulation of IL-6 as well as VSMC migration. Neutralization of IL-6 by its antibody significantly attenuated the migration stimulated by VEGF. Collectively, our data provide the first evidence that intracellular Res and NF-κB are required for VEGF-mediated smooth muscle cell migration. Further, IL-6 induced by VEGF is involved in the ability of the growth factor to stimulate migration.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 669-674 (6 pages)

Journal (Volume, Issue Number)

Biochemical and Biophysical Research Communications (Volume 285, Issue 3)

Publication milestones

  • Published - 2001

Publication status

Published - 2001

ISSN

0006-291X

Publication IDs

  • Scopus: 0034804397
  • PubMed: 11453645

Publication metrics

Metrics

Scopus
citations
SciVal
FWCI
2.17
SciVal
Author count
3
SciVal
citations
88
SciVal
Paper percentile
92
SciVal
Top percentile
10
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
90
Captures
21

Funding Details

This work was supported in part by a grant from the MedCen Foundation and the Clinical Research Center of the Medical Center of Central Georgia. We thank Dr. M. Lienhard Schmitz (German Cancer Research Center, Heidelberg, Germany) for kindly providing plasmid RcCMV-IκB-αM and Benjamin Parrish Mitchell for his effort in the cell culture.